Literature DB >> 11202464

Warfarin therapy and cataract surgery.

A Morris1, M J Elder.   

Abstract

PURPOSE: Cataract extraction in the warfarinized patient poses special considerations. Warfarin will increase the haemorrhagic risk but, more importantly, cessation or reduction in anticoagulation may well lead to serious thromboembolic phenomena. The purpose of this study was to assess the impact that warfarinization has on cataract extraction.
METHODS: One thousand consecutive cataract extractions performed at Christchurch Hospital between 1996 and 1998 were reviewed. Twenty-eight patients (29 eyes) were on warfarin. Reasons for anticoagulation, modification to treatment regimen and postoperative outcome measures were available for 23 eyes or 79% of the study population.
RESULTS: The preoperative international normalized ratio (INR) ranged from 1.00 to 2.40+/-0.37 with a mean of 1.52. No thromboembolic phenomena occurred and four minor perioperative haemorrhages were noted, none of which affected the final visual outcome.
CONCLUSIONS: If warfarin is required to counteract serious thromboembolic tendencies, then it should not be ceased perioperatively. The small numbers of perioperative haemorrhages that did occur were not visually significant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11202464     DOI: 10.1046/j.1442-9071.2000.00350.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  6 in total

1.  The Impact of Uninterrupted Warfarin on Hand and Wrist Surgery.

Authors:  Ljiljana Bogunovic; Richard H Gelberman; Charles A Goldfarb; Martin I Boyer; Ryan P Calfee
Journal:  J Hand Surg Am       Date:  2015-10-01       Impact factor: 2.230

2.  [Perioperative conversion of oral anticoagulants to heparin (bridging) in ophthalmic medicine].

Authors:  N Feltgen; A Pielen; L-O Hattenbach; U Geisen; J Heinz
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

3.  Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery.

Authors:  Pouya N Dayani; M Gilbert Grand
Journal:  Trans Am Ophthalmol Soc       Date:  2006

4.  Discontinuation of warfarin is unnecessary in total knee arthroplasty.

Authors:  David A Rhodes; Erik P Severson; Jeffrey T Hodrick; Harold K Dunn; Aaron A Hofmann
Journal:  Clin Orthop Relat Res       Date:  2010-01       Impact factor: 4.176

5.  Randomised controlled trial on vitreoretinal surgery with and without oral anticoagulants: surgical complications, visual results and perioperative thromboembolic events.

Authors:  Jose Andonegui; Ferran Capdevila; Alicia Zubicoa; Berta Ibáñez
Journal:  Trials       Date:  2019-12-04       Impact factor: 2.279

6.  Subconjunctival hemorrhage: risk factors and potential indicators.

Authors:  Bercin Tarlan; Hayyam Kiratli
Journal:  Clin Ophthalmol       Date:  2013-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.